Who owns exact science?
Ava Robinson
Updated on February 07, 2026
Who owns exact science?
Exact Sciences (company)
| Innovation One, the headquarters of Exact Sciences in Madison, Wisconsin (2020). | |
|---|---|
| Founders | Stanley Lapidus, Anthony P. Shuber |
| Headquarters | Madison, Wisconsin, U.S. |
| Key people | Kevin Conroy (Chairman, President & CEO) Graham Lidgard (Chief Science Officer) |
| Products | Cologuard, Oncotype DX, Oncotype MAP |
What company did exact sciences buy?
Thrive Earlier Detection
Thrive – Exact Sciences Completes Acquisition Of Thrive Earlier Detection, Creating A Leader In Blood-Based, Multi-Cancer Screening.
Does Exas pay a dividend?
EXAS does not currently pay a dividend.
Which are the exact sciences?
Examples of the exact sciences are mathematics, optics, astronomy, and physics, which many philosophers from Descartes, Leibniz, and Kant to the logical positivists took as paradigms of rational and objective knowledge. These sciences have been practiced in many cultures from antiquity to modern times.
Is Exact Sciences a buy?
Exact Sciences has received a consensus rating of Buy. The company’s average rating score is 2.88, and is based on 12 buy ratings, 3 hold ratings, and no sell ratings.
Who is the CEO of Exact Sciences?
Kevin Conroy (Apr 2, 2009–)
EXACT Sciences Corporation/CEO
Kevin Conroy is the Chief Executive Officer, President, and Chairman of the Board of Exact Sciences. He became CEO 11 years ago and he has been part of a team that transformed Exact Sciences into one of the world’s premier cancer diagnostics companies with more than 4,500 employees.
Who are Exact Sciences competitors?
EXACT Sciences’s top competitors include Geneoscopy, Diatech Pharmacogenetics, Biotheranostics and Agendia.
Is Exact Sciences a good investment?
Is statistics an exact science?
Myth 10: Statistics can’t be referred to as an exact science, because it only yields approximate results. Suppose that there is uncertainty regarding whether it will rain tomorrow. It must not be viewed as a defect of statistics. On the contrary, it is this feature which makes statistics a very useful discipline.
Is Exact Sciences a good company?
Great Place to Work and FORTUNE today named Exact Sciences as one of the 2020 Best Workplaces for Millennials. The company is also a member of the 2020 Best Workplaces in Health Care & Biopharma, 2019 Best Workplaces for Women and 2019 Best Workplaces for Diversity lists.
Is exact science profitable?
In summary, the stock of Exact Sciences (NAS:EXAS, 30-year Financials) is believed to be modestly undervalued. The company’s financial condition is fair and its profitability is poor. Its growth ranks in the bottom 10% of the companies in the industry of Medical Diagnostics & Research.
Where is Exact Sciences located?
Madison, Wisconsin
Exact Sciences is located in Madison, Wisconsin, a colorful community combining big city sensibilities with small town charm.
What’s the stock price of Exact Sciences Corporation?
Exact Sciences (EXAS) closed at $60.89 in the latest trading session, marking a -0.56% move from the prior day. Madison-based biotechnology company Promega Corp. is working on producing reagent materials needed in testing for COVID-19. Exact Sciences (EXAS) progressing well in terms of the company’s three priorities.
When is the annual meeting of Exact Sciences?
Exact Sciences Corp. (NASDAQ: EXAS) today highlights data from one oral and one poster presentation being featured at the 2021 Digestive Disease Week® (DDW®) virtual annual meeting, taking place May 21-23. Strength Seen in Exact Sciences (EXAS): Can Its 9.2% Jump Turn into More Strength?
What is the fair value of EXAs stock?
Currency in USD As of 11:37AM EDT. Market open. Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.
How is the market cap of Agilent Technologies determined?
“Market Cap” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
Exact Sciences (EXAS) closed at $60.89 in the latest trading session, marking a -0.56% move from the prior day. Madison-based biotechnology company Promega Corp. is working on producing reagent materials needed in testing for COVID-19. Exact Sciences (EXAS) progressing well in terms of the company’s three priorities.
Exact Sciences Corp. (NASDAQ: EXAS) today highlights data from one oral and one poster presentation being featured at the 2021 Digestive Disease Week® (DDW®) virtual annual meeting, taking place May 21-23. Strength Seen in Exact Sciences (EXAS): Can Its 9.2% Jump Turn into More Strength?
Why is exact sciences ( EXAs ) down so much?
Illumina’s Gene-Sequencing Business Is Rebounding. It’s Girding for an Antitrust Fight. Why Is Exact Sciences (EXAS) Down 8.9% Since Last Earnings Report? Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season? Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Currency in USD As of 11:37AM EDT. Market open. Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.
